Select Medical

SEM

Market cap $2.04B

NEW YORK, June 2, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Select Medical Holdings Corporation (NYSE: SEM) to a consortium led by Select Medical executives and directors. Under the terms of the proposed transaction, shareholders of Select Medical will receive $16.50 in cash for each share of Select Medical that they own. KSF is seeking to determine whet.

NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?

NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/select-medical-merger-lawsuit Why is Select Medical being Investigated?

NEW YORK--(BUSINESS WIRE)---- $SEM #Acquisition--Select Medical Shareholders are Notified of BFA Law's Investigation into the Announced $16.50 per Share Transaction.

NEWTOWN SQUARE, Pa., May 27, 2026 /PRNewswire/ -- Kaskela Law is investigating the recently announced proposed buyout of Select Medical Holdings Corp. (NYSE: SEM) ("Select Medical") shareholders to determine whether the transaction as structured is fair and provides sufficient value to investors for their shares.

Select Medical and Carilion Clinic plan a 50-bed rehab hospital in Virginia as demand continues to grow.

New York, New York--(Newsfile Corp. - May 21, 2026) - Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Select Medical Holdings Corporation (NYSE: SEM) approved a buyout of Select Medical Holdings for inadequate consideration, breaching their fiduciary duties to Select Medical Holdings's shareholders, and whether Select Medical Holdings's shareholders have suffered damages as a result. Attorney Joseph A.

MECHANICSBURG, Pa. and ROANOKE, Va.

Philadelphia, Pennsylvania--(Newsfile Corp. - May 15, 2026) - Stockholder litigation firm Kaskela Law announces that it is investigating the fairness of the recently announced privatization of Select Medical Holdings Corp. ("Select Medical") (NYSE: SEM) on behalf of the company's public shareholders. Click here for additional information: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a price of $16.50 per share in cash.